Browse > Article
http://dx.doi.org/10.4014/mbl.1804.04020

Development of a Blocking ELISA for Measuring Rabies Virus-specific Antibodies in Animals  

Yang, Dong-Kun (Viral Disease Research Division,Animal and Plant Quarantine Agency, MAFRA)
Kim, Ha-Hyun (Viral Disease Research Division,Animal and Plant Quarantine Agency, MAFRA)
Ryu, Jieun (Bionote)
Gee, Mi-ryun (Viral Disease Research Division,Animal and Plant Quarantine Agency, MAFRA)
Cho, In-Soo (Viral Disease Research Division,Animal and Plant Quarantine Agency, MAFRA)
Publication Information
Microbiology and Biotechnology Letters / v.46, no.3, 2018 , pp. 269-276 More about this Journal
Abstract
Rabies virus (RABV)-specific antibodies in animals and humans are measured using standard methods such as fluorescent antibody virus neutralization (FAVN) tests and rapid fluorescent focus inhibition tests, which are based on cell culture systems. An alternative assay that is safe and easy to perform is required for rapid sero-surveillance following mass vaccination of animals. Two purified monoclonal antibodies (4G36 and B2H17) against RABV were selected as capture and detection antibodies, respectively. A genetically modified RABV, the ERAGS strain, was propagated and concentrated by polyethylene glycol precipitation. Optimal conditions for the RABV antigen, antibodies, and serum dilution for a blocking enzymelinked immune sorbent assay (B-ELISA) were established. We evaluated the sensitivity, specificity, and accuracy of the B-ELISA using serum samples from 138 dogs, 71 raccoon dogs, and 25 cats. The B-ELISA showed a diagnostic sensitivity of 95.8-96.3%, specificity of 91.3-100%, and accuracy of 96.0-97.2% compared to the FAVN test. These results suggest that the B-ELISA is useful for sero-surveillance of RABV in dogs, raccoon dogs, and cats.
Keywords
Rabies; blocking ELISA; antibody detection; dogs;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Smith JS, Yager PA, Baer GM. 1973. A rapid reproducible test for determining rabies neutralizing antibody. Laboratory Techniques in Rabies. 4: 181-192.
2 Muhamuda K, Madhusudana SN, Ravi V. 2007. Development and evaluation of a competitive ELISA for estimation of rabies neutralizing antibodies after post-exposure rabies vaccination in humans. Int. J. Infect. Dis. 11: 441-445.   DOI
3 He Y, Gao D, Zhang M. 2006. Expression of the nucleoprotein gene of rabies virus for use as a diagnostic reagent. J. Virol. Methods. 138: 147-151.   DOI
4 Inoue S, Motoi Y, Kashimura T, Ono K, Yamada A. 2003. Safe and easy monitoring of anti-rabies antibody in dogs using his-tagged recombinant N-protein. Jpn. J. Infect. Dis. 56: 158-160.
5 Kucinskaite I, Juozapaitis M, Serva A, Zvirbliene A, Johnson N, Staniulis J, et al. 2007. Antigenic characterisation of yeastexpressed lyssavirus nucleoproteins. Virus Genes. 35: 521-529.   DOI
6 Reid-Sanden FL, Sumner JW, Smith JS, Fekadu M, Shaddock JH, Bellini WJ. 1990. Rabies diagnostic reagents prepared from a rabies N gene recombinant expressed in baculovirus. J. Clin. Microbiol. 28: 858-863.
7 Sugiyama M, Yoshiki R, Tatsuno Y, Hiraga S, Itoh O, Gamoh K, et al. 1997. A new competitive enzyme-linked immunosorbent assay demonstrates adequate immune levels to rabies virus in compulsorily vaccinated Japanese domestic dogs. Clin. Diagn. Lab. Immunol. 4: 727-730.
8 Yang DK, Kim HH, Lee SH, Ji M, Cho IS. 2017. Indirect ELISA for the Detection of Rabies Virus Antibodies in Dog Sera. J. Bacteriol. Virol. 47: 148.   DOI
9 World Organization for Animal Health (OIE). 2012. Manual of diagnostic tests and vaccines for terrestrial animals, pp 263-282. 7th Ed.
10 Fitzgerald E. 1996. Potency test for antirabies serum and immunoglobulin. Laboratory Techniques in Rabies 4: 417-422.
11 Franka R, Smith TG, Dyer JL, Wu X, Niezgoda M, Rupprecht CE. 2013. Current and future tools for global canine rabies elimination. Antiviral. Res. 100: 220-225.   DOI
12 Reed LJ, Muench H. 1938. A simple method of estimating fifty per cent endpoints. Am. J. Epidemiol. 27: 493-497.   DOI
13 Lewis GD, Metcalf TG. 1988. Polyethylene glycol precipitation for recovery of pathogenic viruses, including hepatitis A virus and human rotavirus, from oyster, water, and sediment samples. Appl. Environ. Microbiol. 54: 1983-1988.
14 Nakane PK, Kawaoi A. 1974. Peroxidase-labeled antibody. A new method of conjugation. J. Histochem. Cytochem. 22: 1084-1091.   DOI
15 Cliquet F, McElhinney LM, Servat A, Boucher JM, Lowings JP, Goddard T, et al. 2004. Development of a qualitative indirect ELISA for the measurement of rabies virus-specific antibodies from vaccinated dogs and cats. J. Virol. Methods. 117: 1-8.   DOI
16 Knoop EV, Freuling CM, Kliemt J, Selhorst T, Conraths FJ, Muller T. 2010. Evaluation of a commercial rabies ELISA as a replacement for serum neutralization assays as part of the pet travel scheme and oral vaccination campaigns of foxes. Berl. Munch. Tierarztl Wochenschr. 123: 278-285.
17 Esterhuysen JJ, Prehaud C, Thomson GR. 1995. A liquid-phase blocking ELISA for the detection of antibodies to rabies virus. J. Virol. Methods. 51: 31-42.   DOI
18 Cliquet F, Aubert M, Sagne L. 1998. Development of a fluorescent antibody virus neutralisation test (FAVN test) for the quantitation of rabies-neutralising antibody. J. Immunol. Methods. 212: 79-87.   DOI
19 Cheong Y, Kim B, Lee KJ, Park D, Kim S, Kim H, et al. 2014. Strategic model of national rabies control in Korea. Clin. Exp. Vaccine Res. 3: 78-90.   DOI
20 Yang DK, Kim HH, Lee KK, Yoo JY, Seomun H, Cho IS. 2017. Mass vaccination has led to the elimination of rabies since 2014 in South Korea. Clin. Exp. Vaccine Res. 6: 111-119.   DOI